P019 What's Hot in Pediatric Dermatology
DESCRIPTION
There have been many exciting recent developments in pediatric dermatology. This session will focus on emerging trends and advances in inflammatory, infectious, and neoplastic skin conditions that affect children, with emphasis on diagnostic and treatment strategies including the use of systemic therapies. Updates on acne, atopic dermatitis, vulvar dermatoses, vascular anomalies, and cutaneous infections in pediatric patients will be provided.
LEARNING OBJECTIVES
Recognize etiologic factors and clinical manifestations of inflammatory, infectious, and neoplastic disorders in pediatric patients and use these observations to formulate state-of-the art management strategies
Utilize recent advances to evaluate and treat acne, atopic dermatitis, vulvar dermatoses, vascular anomalies, and cutaneous infections in pediatric patients
Employ dermatologic procedures safely and effectively in pediatric patients.
SCHEDULE
6:00 PM
Introduction
Julie V. Schaffer, MD, FAAD
6:05 PM
What's hot in pediatric acne and acne-ish lesions
Dawn Eichenfield, PhD, MD, FAAD
6:35 PM
Q & A
Dawn Eichenfield, PhD, MD, FAAD
6:40 PM
What's hot in pediatric procedural dermatology
Maria Gnarra Buethe, MD, PhD, FAAD
7:10 PM
Q & A
Maria Gnarra Buethe, MD, PhD, FAAD
7:15 PM
Vulvar dermatoses in prepubertal girls
Sarah Stein, MD, FAAD
7:45 PM
Q & A
Sarah Stein, MD, FAAD
7:50 PM
Pediatric atopic dermatitis: what's new and what's true
Lacey Lea Kruse, MD
8:20 PM
Q & A
Lacey Lea Kruse, MD
8:25 PM
Hot topics in pediatric skin infections
Julie V. Schaffer, MD, FAAD
8:55 PM
Q & A
Julie V. Schaffer, MD, FAAD
SPEAKERS
Maria Gnarra Buethe, MD, PhD, FAAD
Children's Hospital of Orange County/University of California Irvine
Dawn Eichenfield, PhD, MD, FAAD
Lacey Lea Kruse, MD
Julie V. Schaffer, MD, FAAD
Sarah Stein, MD, FAAD
SPEAKER DISCLOSURES
Maria Gnarra Buethe, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Dawn Eichenfield, PhD, MD, FAAD
Amryt Pharma/ Chiesi Farmaceutici – Consultant(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Beiersdorf, Inc. – Speaker(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma Laboratories, LP – Speaker(Fees); Incyte Corporation – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); NobelPharma – Advisory Board(Fees), Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pelthos Therapeutics – Advisory Board(Fees); Sanofi/Regeneron – Speaker(Fees), Speaker(Honoraria); Solici – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Fees), Speaker(Fees);
Lacey Lea Kruse, MD
Eli Lilly and Company – Investigator(Grants/Research Funding); LEO Pharma, US – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding);
Julie V. Schaffer, MD, FAAD
American Board of Dermatology – Employee(Salary); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);
Sarah Stein, MD, FAAD
No financial relationships exist with ineligible companies.